These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9398008)

  • 1. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors.
    Tacke M; Schmolke S; Schlueter V; Sauleda S; Esteban JI; Tanaka E; Kiyosawa K; Alter HJ; Schmitt U; Hess G; Ofenloch-Haehnle B; Engel AM
    Hepatology; 1997 Dec; 26(6):1626-33. PubMed ID: 9398008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
    Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
    J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations.
    Nübling CM; Bialleck H; Fürsch AJ; Scharrer I; Schramm W; Seifried E; Schmidt U; Staszewski S; Löwer J
    J Med Virol; 1997 Nov; 53(3):218-24. PubMed ID: 9365885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
    Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
    J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
    Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
    Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs.
    Tàssies D; Magallón M; Quintana M; Fernández-Urgellés RP; Rodriguez-Pinto C; Tusell J; Altisent C; Reverter JC; Mazzara R; Ordinas A; Monteagudo J
    Haematologica; 1999 Oct; 84(10):930-6. PubMed ID: 10509042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GBV-C/HGV infection in end-stage renal disease: a serological and virological survey.
    Fabrizi F; Lunghi G; Pozzi C; Colzani S; Tentori F; Del Vecchio L; Corti M; Pagano A; Locatelli F
    J Nephrol; 2000; 13(1):68-74. PubMed ID: 10720218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
    Kaya S; Cicioğlu Aridoğan B; Demirci M
    Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
    Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of hepatitis G virus RNA and antibodies to HGV envelope protein (anti-E2) in patients with liver injury in Japan].
    Matsushita E; Kaneko S; Kobayashi K
    Nihon Rinsho; 1999 Jun; 57(6):1274-8. PubMed ID: 10390982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
    Hassoba HM; Terrault NA; el-Gohary AM; Scheffel C; Jou C; Brackett J; Hunt J; Lou SC; Wright TL
    J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study.
    Tagger A; Donato F; Ribero ML; Chiesa R; Tomasoni V; Portera G; Gelatti U; Albertini A; Fasola M; Nardi G
    Hepatology; 1997 Dec; 26(6):1653-7. PubMed ID: 9398012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.
    Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T
    Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune responses to the GB virus C/hepatitis G virus envelope 2 protein.
    Lazdina U; Hultgren C; Chen M; Fischler B; Weiland O; Mushahwar IK; Sällberg M
    J Med Virol; 2000 Nov; 62(3):334-44. PubMed ID: 11055243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatitis G virus envelope protein E2 antibody in blood donors.
    Ramezani A; Gachkar L; Eslamifar A; Khoshbaten M; Jalilvand S; Adibi L; Salimi V; Hamkar R
    Int J Infect Dis; 2008 Jan; 12(1):57-61. PubMed ID: 17629534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
    Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
    J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.